Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
Chadi Rakieh, Philip G ConaghanLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UKAbstract: Biologic therapies in rheumatoid arthritis are now part of standard practice for disease that proves difficult to con...
Saved in:
Main Authors: | Rakieh C (Author), Conaghan PG (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
by: R. Ariza, et al.
Published: (2014) -
EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: Ye. I. Alekseyeva, et al.
Published: (2011) -
EXPERIENCE OF TREATMENT WITH ABATACEPT IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS
by: Ye. I. Alekseyeva, et al.
Published: (2011) -
Effectiveness and Safety of Abatacept in Moderate to Severe Rheumatoid Arthritis
by: Lucía Cortejoso-Fernández, et al.
Published: (2011) -
Majocchi's granuloma developing in the setting of abatacept use for rheumatoid arthritis
by: Natalie Villa, et al.
Published: (2020)